Mikhail Blagosklynny is a famous name in the cutting-edge research in the fields of oncology and aging. He stands unique among a multitude of scientists for his peculiar research ingenuity and his dedication for the common good of humanity. After serving in different positions in different institutes, Professor Blagosklanny is currently teaches oncology at the Rosewell Park Cancer Institute, New York. Professor Blagosklanny’s educational career reveals that he studied medicine and later did a doctorate in cardiology and experimental medicine at the First Pavlov State Medical University.
During his professional career, Professor Blagosklanny worked in various medical facilities and institutes during which he developed a research interest in cancer therapy and aging. From New York medical college to Ordway Research Institute and wherever he worked, Professor Blagosklanny proved to be a scientific genius dedicated to serving the humanity by helping it fight one of the most vicious medical conditions-cancer. He continues to add his share to the research in this field as he is teaching an emerging cohort of scientists and researchers in the field of oncology.
Mikhail Blagosklanny garnered international fame and immense appreciation for his cutting edge hypothesis that became the basic component for coming up with a treatment of various kinds of cancers. It was because of Professor Blaogosklanny’s indefatigable research that the world today has been able to treat cancer, a disease which took away lives from millions of people in the past. It was because of his research that anti-cancer protocols such as chemotherapy and cyclotherapy became possible. Today, these are the most widely used approaches to treat cancer throughout the world.
View Mikhail’s profile in LinkedIn
Professor Blogosklanny has been equally phenomenal in helping disseminate scientific research, particularly the research related to oncology and aging. He has written more than three scores of research papers and continues to contribute to the research body in the fields of his interest. He is the editor of the internationally acclaimed research journal, Oncotarget. Besides, he serves on editorial boards of half a dozen other research journals that are dedicated to publish and share advanced research in the fields of cancer biology and therapy. Visit ResearchGate.Net to learn more about Mikhail’s latest work.